Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms
Femtrace has been approved for the relief of the vasomotor symptoms of menopause. Approval was not granted for the secondary indication of vulvar-vaginal atrophy. The comapny expects to launch Femtrace in the first quarter of 2005.Posted: August 2004
Femtrace (estradiol acetate) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
